Arthritis is a degenerative disease characterized by joint pain . People suffering from severe forms of arthritis experience an impaired quality of life and are faced with few treatment options that provide long-term relief . The most common types of
arthritis are osteoarthritis and rheumatoid arthritis, the former of which is the focus of this pilot study.
Osteoarthritis is a dynamic but gradual disease that can ultimately lead to loss of joint function or significant disablement [3,4]. Currently, there is no cure for arthritis, and treatment options focus mainly on symptom management .
Traditional options for treating arthritis include oral nonsteroidal anti-inflammatory drugs (NSAIDS), acetaminophen, and corticosteroid injections; which come with side effects such
as abdominal pain and damage to central organs [5-7]. Nonpharmacological treatments include diet management to reduce strain on the joints, exercise to improve mobility, splints and joint protection techniques, hot and cold therapy, chiropractics, physiotherapy, acupuncture and more invasive treatments like surgery [1,6]. The relative lack of viable long-term nonpharmacological treatments for arthritis combined with the risks of drug therapy provided the motivation for this study, especially since past studies involving pulsed electromagnetic field therapy (PEMFT) have found no adverse effects on the body, even after
prolonged use .
PEMF technology was officially approved by the Food and Drug Administration (FDA) in 1979 and has been used to treat various ailments and illnesses for the past 50 years . The
therapy was originally used to treat non-union bone fractures and is now used to treat rotator cuff tendinitis, peripheral nerve regeneration, and various other illnesses and ailments of the bone and ligaments causing pain and swelling . Since PEMFT has been recognized to improve circulation and promote healing of inflammation-related pain , it shows promise as a treatment for arthritis. Using PEMFT to treat patients with arthritis is not common practice [1,6] and has not been approved by Health Canada. This study attempts to determine if PEMFT (provided by the Centurion EZY System) can alleviate symptoms of arthritis such as pain, swelling, and immobility, based on a combination of
subjective and objective tests.
Read More: NTAB Research Study